嘉吉和 Enough 扩大合作伙伴关系，利用发酵蛋白技术开发可持续的替代肉类和乳制品。 Cargill and Enough expand partnership to develop sustainable alternative meat and dairy products using fermented protein technology.

嘉吉和食品技术公司 Enough 正在扩大合作伙伴关系，以开发更多替代肉类和乳制品解决方案。 Cargill and food technology company Enough are expanding their partnership to develop more alternative meat and dairy solutions. 嘉吉投资了 Enough 的 C 轮融资，并签订了使用和销售 Enough 发酵蛋白的商业协议。 Cargill has invested in Enough's Series C funding round and entered into a commercial agreement to use and market Enough's fermented protein. Enough 生产 Abunda 真菌蛋白，它是通过可持续、零废物发酵过程产生的。 Enough produces Abunda mycoprotein, which is created through a sustainable, zero-waste fermentation process. 真菌蛋白是一种完整的食品成分，含有必需氨基酸和高膳食纤维。 The mycoprotein is a complete food ingredient containing essential amino acids and high in dietary fiber. 扩大的合作伙伴关系将使嘉吉能够创造含有 Abunda 真菌蛋白的替代蛋白质食品，同时利用其在植物蛋白、组织剂和脂肪方面的专业知识。 The expanded partnership will enable Cargill to create alternative protein-based foods containing Abunda mycoprotein while leveraging its expertise in plant-based proteins, texturizers, and fats.